Skip to main content
. 2017 Apr 28;9:251–260. doi: 10.2147/CEOR.S130334

Table 6.

Predictors of MS-related hospital visits, ER visits, and outpatient visits in patients with MS treated with DMTs (n=12,431)

Variables Hospital visitsa P-value ER visitsa P-value Outpatient visitsb P-value
Sex
 Female Reference Reference Reference
 Male 0.939 (0.799–1.104) 0.4478 0.826 (0.737–0.925) 0.0009 –0.019 (0.152) 0.901
Age at index DMT 1.029 (1.022–1.036) <0.0001 0.992 (0.988–0.997) 0.0009 0.01 (0.006) 0.110
CCI score
 0 Reference Reference Reference
 1 1.239 (1.053–1.457) 0.0097 1.457 (1.304–1.628) <0.0001 1.035 (0.148) <0.0001
 2 1.767 (1.421–2.198) <0.0001 1.81 (1.545–2.12) <0.0001 0.94 (0.229) <0.0001
 ≥3 1.678 (1.374–2.048) <0.0001 2.052 (1.782–2.364) <0.0001 1.724 (0.206) <0.0001
PDC group
 <0.8 Reference Reference Reference
 ≥0.8 0.478 (0.417–0.547) <0.0001 0.62 (0.565–0.681) <0.0001 –0.712 (0.132) <0.0001

Notes:

a

Values represent point estimates for the OR (95% CI) generated by logistic regression;

b

values represent coefficient estimates (SE) generated by ordinal least-squares regression.

Abbreviations: MS, multiple sclerosis; ER, emergency room; DMTs, disease-modifying therapies; CCI, Charlson Comorbidity Index; PDC, proportion of days covered; OR, odds ratio; CI, confidence interval; SE, standard error.